[New specialty drugs admitted in Austria and new knowledge regarding drugs already in longer use. Leucomax-Aesca dry injection ampule with solution. Leucomax-Sandoz dry injection ampule with solution].
R
R
Haas
D017088:AIDS-Related Opportunistic Infections / Q000097:blood / Q000628:therapy; D000741:Anemia, Aplastic / Q000097:blood / Q000628:therapy; D001317:Austria; D016026:Bone Marrow Transplantation; D003586:Cytomegalovirus Infections / Q000097:blood / Q000628:therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000628:therapy; D007970:Leukopenia / Q000097:blood / Q000628:therapy; D009369:Neoplasms / Q000097:blood / Q000628:therapy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor